Published: 5 March 2021
Author(s): Manuel Martínez-Sellés, Maricela Valerio-Minero, María Carmen Fariñas, Hugo Rodríguez-Abella, María Luisa Rodríguez, Aristides de Alarcón, Encarnación Gutiérrez-Carretero, Manuel Cobo-Belaustegui, Miguel Ángel Goenaga, Asunción Moreno-Camacho, Fernando Domínguez, Laura García-Pérez, Laura Domínguez-Pérez, Patricia Muñoz, on behalf of the Spanish Collaboration on Endocarditis—Grupo de Apoyo al Manejo de la Endocarditis infecciosa en ESpaña (GAMES)
Infective endocarditis (IE) is a serious condition with a poor prognosis [1,2]. Solid organ transplantation (SOT) is an established and practical definitive treatment option for patients with end-organ dysfunction [3]. SOT recipients are a complex group of patients with high risk of infection, given their underlying immunosuppression and frequent interventions. Infection remains a common cause of morbidity and mortality and SOT is recognized to be associated with bacteremia [4].
